New Pfizer COVID-19 Drug 89 Percent Effective in Trials

Pharmaceutical giant Pfizer has announced the results of an experimental antiviral drug that can reduce the likelihood of hospitalisation or death for adults at risk of severe COVID by 89 percent. The data was uploaded by Pfizer through its official ...

from Google Alert - Business https://ift.tt/3o6OFPD
Pharmaceutical giant Pfizer has announced the results of an experimental antiviral drug that can reduce the likelihood of hospitalisation or death for adults at risk of severe COVID by 89 percent. The data was uploaded by Pfizer through its official ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize